Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
7,254,615
-
Total 13F shares
-
4,206,014
-
Share change
-
-268,786
-
Total reported value
-
$16,401,762
-
Price per share
-
$3.90
-
Number of holders
-
38
-
Value change
-
-$1,447,299
-
Number of buys
-
12
-
Number of sells
-
11
Institutional Holders of Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR) as of Q3 2025
As of 30 Sep 2025,
Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,206,014 shares.
The largest 10 holders included
BML Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Stonepine Capital Management, LLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, ACADIAN ASSET MANAGEMENT LLC, Peapod Lane Capital LLC, ADAR1 Capital Management, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.